Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Core EBITDA Growth

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) 89.44-31.9410.9452.6349.62

What is the latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA ?

The latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA is 89.44 based on Mar2023 Standalone results.
Year Core EBITDA Growth
Mar202389.44
Mar2022-31.94
Mar202110.94
Mar202052.63
Mar201949.62

How is Core EBITDA Growth of ASTRAZENECA PHARMA INDIA Trending?

Years Core EBITDA Growth % Change
Mar2023 89.44
Positive
Mar2022 -31.94
Negative
Mar2021 10.94
-79.21
Mar2020 52.63
6.07
Mar2019 49.62 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare Core EBITDA Growth ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹14,394.4 Cr 5.8% 10.6% 75.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,290.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹113,357.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹111,134.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹104,235.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,001.5 Cr -1% -2.4% 28.4% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

5.8%

10.6%

75.1%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses